\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes MSCAFor the MSCA Staff Exchanges 2022 call (call deadline 8 March 2023 17:00 Brussels time) an adjustment has been made to the call document HEU MSCA SE application form template, more specifically under part B1:
We would like to draw your attention to an important update of the submission template part B1. In accordance with the Horizon Europe Framework Programme rules, Associated Partners can be Work Package's leaders. Therefore, the footnote “7 - A "lead beneficiary" must be a beneficiary (= organisation established in a Member State/Associated Countries) and cannot be an associated partner” preventing the appointment of Associated Partners as Work Packages’ leaders in the proposal, has been removed. A new template Part B1 has been republished for your kind consideration and use. (Funding and Tender portal)
To sum up, associated partners can be work package leaders but cannot be coordinators. Only beneficiaries can coordinate a MSCA Staff Exchanges project.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
